Post by Pierre Fabre Oncology

As the global GI oncology community gathers in Munich, Pierre Fabre Oncology is excited to contribute to the conversations shaping the future of cancer care. We are looking forward to participating in the ESMO Gastrointestinal Cancers Congress 2026 (July 1–4), where more than 3,800 attendees from over 100 countries are expected to come together. At Pierre Fabre Oncology, we are committed to advancing innovation in GI oncology and precision medicine to help improve the outcomes for patients with metastatic colorectal cancers. 📍 Visit us at our booth #27 to connect with our team, exchange insights, and explore opportunities for collaboration. #PierreFabre #ESMOGI26 #GIOncology #PrecisionMedicine #CancerResearch #ColorectalCancer